New Risk • May 05
New major risk - Negative shareholders equity The company has negative equity. Total equity: -€938k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€4.8m free cash flow). Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€938k). Market cap is less than US$10m (€6.47m market cap, or US$7.57m). Minor Risk Revenue is less than US$5m (€2.0m revenue, or US$2.3m). New Risk • Mar 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€5.1m free cash flow). Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (€6.69m market cap, or US$7.70m). Minor Risk Revenue is less than US$5m (€2.4m revenue, or US$2.7m). Duyuru • Jan 31
AMA Corporation Plc to Report Fiscal Year 2025 Results on Apr 30, 2026 AMA Corporation Plc announced that they will report fiscal year 2025 results at 5:40 PM, Central European Standard Time on Apr 30, 2026 New Risk • Jan 23
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €8.29m (US$9.76m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€5.1m free cash flow). Market cap is less than US$10m (€8.29m market cap, or US$9.76m). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (€2.4m revenue, or US$2.8m). Reported Earnings • Nov 04
First half 2025 earnings released: €0.054 loss per share (vs €0.089 loss in 1H 2024) First half 2025 results: €0.054 loss per share (improved from €0.089 loss in 1H 2024). Revenue: €1.18m (down 8.5% from 1H 2024). Net loss: €2.89m (loss narrowed 39% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Duyuru • Nov 04
AMA Corporation Plc to Report Q4, 2025 Results on Jan 31, 2026 AMA Corporation Plc announced that they will report Q4, 2025 results on Jan 31, 2026 Duyuru • Aug 02
AMA Corporation Plc to Report First Half, 2025 Results on Oct 31, 2025 AMA Corporation Plc announced that they will report first half, 2025 results on Oct 31, 2025 Reported Earnings • May 02
Full year 2024 earnings released: €0.20 loss per share (vs €0.22 loss in FY 2023) Full year 2024 results: €0.20 loss per share (improved from €0.22 loss in FY 2023). Revenue: €2.49m (down 17% from FY 2023). Net loss: €7.34m (loss narrowed 8.6% from FY 2023). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings. New Risk • Jan 15
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -€6.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€6.3m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 11% per year over the past 5 years. Minor Risks Revenue is less than US$5m (€2.6m revenue, or US$2.7m). Market cap is less than US$100m (€10.4m market cap, or US$10.7m). Duyuru • Jan 15
AMA Unveils Groundbreaking AI Innovations to Empower Frontline Workers AMA announced a suite of cutting-edge AI-driven innovations designed to transform operations, empower professionals, and streamline collaboration across industries. These advancements mark a significant step forward in the evolution of AMA's AI-powered solutions tailored to frontline needs. Merlin, AI assistant, empowers frontline workers with precise, context-aware video responses and real-time insights. Whether troubleshooting machinery, conducting inspections, or training new hires, Merlin has the ability to provide immediate access to relevant video sequences when and where they are needed most. This intelligent assistant adapts to the daily challenges of frontline professionals, boosting efficiency, accuracy, and confidence. example: A technician repairing an air conditioner encounters an unfamiliar issue. By asking Merlin, he instantly receives the relevant video tutorial sequence for the specific model, saving time and ensuring a quick and reliable resolution. Live translation: Breakdownlanguagebarriers: Communication knows no boundaries with AMA's live translation. This advanced feature delivers real-time multilingual communication through both speech-to-text and speech-to-speech translation options. Teams collaborating across geographies and languages can now overcome linguistic barriers to facilitate skill sharing and decision-making. example: During a multinational factory audit, team members from different countries collaborate in real-time using XpertEye. Live translation ensures everyone's input is understood, enabling productive discussions without delays. AI Report enables organizations to record XpertEye sessions and effortlessly generate actionable insights. Users can access: Session summaries: Concise, clear overviews of activities. Multilingual transcripts: Organized by chapters and topics to enhance clarity. Action points: Highlighted tasks and priorities for swift follow-up. Customizable reports: Tailor prompts, formats, and content to align with specific workflows and organizational needs. By simplifying complex data and enabling detailed yet streamlined reporting, AI Report saves time and strengthens accountability. It is an essential tool for enhancing efficiency and decision-making in today's fast-paced work environments. example: The entire session is recorded using XpertEye during a factory machinery inspection. Once the session concludes, AI Report generates a comprehensive summary, highlighting critical maintenance steps and providing a multilingual report that can be easily shared with international teams for swift action. Full-body anonymization: Protect privacy without compromise:AMA prioritizes privacy and security with its full- body anonymization feature. This technology ensures compliance with privacy regulations without hindering operational performance by blurring personal identifiers while preserving critical visual elements, such as hand movements or tools. example: A manufacturing plant uses XpertEye video recordings for training purposes. Full-body anonymizationblurs the workers' identities while maintaining clear visibility of placements and tool usage, ensuring effective learning while protecting privacy. New Risk • Sep 24
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €8.86m (US$9.90m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Market cap is less than US$10m (€8.86m market cap, or US$9.90m). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€5.7m net loss in 2 years). Revenue is less than US$5m (€3.0m revenue, or US$3.4m). New Risk • Aug 09
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.02m (US$9.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Market cap is less than US$10m (€9.02m market cap, or US$9.85m). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€5.7m net loss in 2 years). Revenue is less than US$5m (€3.0m revenue, or US$3.3m). Reported Earnings • Apr 28
Full year 2023 earnings: Revenues in line with analyst expectations Full year 2023 results: Revenue: €3.01m (down 30% from FY 2022). Net loss: €8.08m (loss narrowed 62% from FY 2022). Revenue was in line with analyst estimates. Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 9.2% growth forecast for the Software industry in France. New Risk • Apr 24
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 137% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (41% average weekly change). Shareholders have been substantially diluted in the past year (137% increase in shares outstanding). Market cap is less than US$10m (€9.05m market cap, or US$9.67m). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€8.1m net loss in 2 years). Revenue is less than US$5m (€3.8m revenue, or US$4.1m). Duyuru • Feb 02
AMA Corporation Plc to Report Q1, 2024 Results on Apr 30, 2024 AMA Corporation Plc announced that they will report Q1, 2024 results on Apr 30, 2024 Duyuru • Feb 01
AMA CORPORATION PLC and ROFIM Unveil the First Global Surgical Teleassistance Solution AMA CORPORATION PLC and ROFIM announced the launch of a global solution for surgical remote assistance, covering the pre-, per- and post-operative phases. This integrated solution, accessible via a web browser, extends from tele-expertise to remote expert assistance. It enables medical centers to request a specialist opinion from a reference center by transmitting the patient's medical file and preoperative images (CT scans, MRIs, etc.) and organizing inter-center multidisciplinary meetings. During the operation, due to assisted reality, the surgeon can share his or her point of view in real-time with a remote expert. The expert receives various video streams simultaneously (connected glasses, third-party cameras, endoscopy column, etc.) and benefits from advanced functionalities such as video pointing, annotations, live document sharing, zoom, and brightness and contrast control. This innovative solution, the result of collaboration between AMA and ROFIM, has its origins in a long-term partnership with the "Bloc OPératoire Augmenté" innovation chair, known as BOPA (AP-HP, Mines Telecom Institut, University of Paris Saclay). It has already been used in several healthcare establishments, including BOPA, and deployed by the ARS and GRADeS in French Guiana and Martinique. According to Pr. Éric Vibert, transplant surgeon at the Paul-Brousse AP-HP hospital and founder of the BOPA Innovation Chair, the emergence of this solution under the impetus of Dr. Daniel Pietrasz is a fine illustration of the dynamic transformation of operating room practices with the arrival of new digital tools, particularly as it encourages new forms of cooperation between centers. As such, it is in line with the major orientations of the France 2030 plan, launched by the French government to support and accelerate innovation in healthcare and the continuous improvement of care. New Risk • Nov 14
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Market cap is less than US$10m (€3.45m market cap, or US$3.74m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Currently unprofitable and not forecast to become profitable over next 3 years (€7.9m net loss in 3 years). Revenue is less than US$5m (€4.3m revenue, or US$4.7m). New Risk • Oct 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Market cap is less than US$10m (€1.80m market cap, or US$1.89m). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (€4.9m net loss in 3 years). Revenue is less than US$5m (€4.3m revenue, or US$4.5m). Major Estimate Revision • Jun 21
Consensus EPS estimates upgraded to €0.29 loss, revenue downgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from €5.40m to €5.30m. 2023 losses expected to reduce from -€0.33 to -€0.29 per share. Software industry in France expected to see average net income growth of 15% next year. Consensus price target of €0.30 unchanged from last update. Share price fell 6.4% to €0.25 over the past week. Reported Earnings • Apr 30
Full year 2022 earnings released Full year 2022 results: Revenue: €4.29m (down 35% from FY 2021). Net loss: €21.4m (loss widened 117% from FY 2021). Revenue is forecast to grow 29% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Software industry in France. Duyuru • Jan 31
AMA Corporation Plc to Report Fiscal Year 2022 Results on Apr 28, 2023 AMA Corporation Plc announced that they will report fiscal year 2022 results at 9:00 AM, Central European Standard Time on Apr 28, 2023 Duyuru • Jan 20
AMA Corporation plc Announces Its Launch of XpertEye Version 7 AMA Corporation Plc announced its launch of XpertEye version 7. Its software platform includes new features designed to facilitate integration within businesses and major groups. This new version follows a few weeks after the introduction of a free trial offer for XpertEye Lite, enabling anyone with a smartphone to try out XpertEye Lite for 15 days. New features integrated making the use of XpertEye even more fluid and easily accessible. Version 7 of XpertEye is available to clients from January 19, 2023 and will cover the three versions of the assisted reality solution XpertEye (Lite, Essential and Advanced). Following the integration of the “On and Live” and “Record” features with versions 6, this version 7 offers XpertEye users a number of new features covering one-to-one or multi-user conference scheduling and management, thanks in particular to integration with Microsoft Outlook and other third-party applications. XpertEye Lite and XpertEye Advanced have also been further enhanced with an option to carry out user satisfaction surveys. These surveys, which are compatible, amongst others, with Microsoft Dynamics and Microsoft Forms, can be fully customized. For instance, they will help improve XpertEye’s deployment and use. The results are consolidated in a dashboard for overall monitoring. Price Target Changed • Nov 16
Price target decreased to €1.10 Down from €1.50, the current price target is provided by 1 analyst. New target price is 103% above last closing price of €0.54. Stock is down 83% over the past year. The company is forecast to post a net loss per share of €0.51 next year compared to a net loss per share of €0.50 last year. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Pascale Laverriere was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 31
First half 2022 earnings released: €0.38 loss per share (vs €0.17 loss in 1H 2021) First half 2022 results: €0.38 loss per share (further deteriorated from €0.17 loss in 1H 2021). Revenue: €2.13m (down 46% from 1H 2021). Net loss: €8.46m (loss widened 197% from 1H 2021). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Software industry in France. Duyuru • May 02
AMA Corporation PLC to Report Q3, 2022 Results on Oct 31, 2022 AMA Corporation PLC announced that they will report Q3, 2022 results Pre-Market on Oct 31, 2022 Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Pascale Laverriere was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 01
First half 2021 earnings released The company reported a soft first half result with weaker control over costs, although losses were stable and revenues were flat. First half 2021 results: Revenue: €3.94m (flat on 1H 2020). Net loss: €2.85m (flat on 1H 2020). 